Tolinapant efficacy in a subset of triple negative breast cancers
$200,000U54FY2022CANIH
University Of Utah, Salt Lake City UT
Investigators
Linked publications & trials
Paper 39713418Paper 39082680Paper 39056190Paper 38969867Paper 38781103Paper 38641411Paper 38559060Paper 38098449Paper 37578979Paper 37071495Paper 36880458Paper 36876914Paper 36088362Paper 36007109Paper 36001024Paper 35857626Paper 35697909Paper 35221336Paper 35017531Paper 34951956Paper 34711608Paper 34429404Paper 34103681Paper 33415312Paper 33292639Paper 32321829Paper 32152150Paper 30833748
Abstract
Project Summary/Abstract N/A
View original record on NIH RePORTER →